Sa502 THE FIRST AND SECOND WAVE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A TEMPORAL TREND ANALYSIS

Παρόμοια τεκμήρια

• Effect of IBD medications on COVID-19 outcomes: results from an international registry
  ανά: Ungaro, Ryan C, κ.ά.
  Έκδοση: (2021)
• Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry
  ανά: Agrawal, Manasi, κ.ά.
  Έκδοση: (2020)
• Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry
  ανά: Brenner, Erica J., κ.ά.
  Έκδοση: (2020)
• Fr509 COVID-19 OUTCOMES AMONG RACIAL AND ETHNIC MINORITY INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASES IN THE UNITED STATES
  ανά: Agrawal, Manasi, κ.ά.
  Έκδοση: (2021)
• Fr498 NEW GASTROINTESTINAL SYMPTOMS ARE COMMON IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH COVID-19: DATA FROM AN INTERNATIONAL REGISTRY
  ανά: Ungaro, Ryan C., κ.ά.
  Έκδοση: (2021)